Thimar Development Holding Company (TADAWUL:4160)
Saudi Arabia · Delayed Price · Currency is SAR 36.26
+1.28 (3.66%)
Jul 31, 2025, 3:19 PM AST
Elevation Oncology Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Operating Revenue | - | - | - | - | 0.43 | 3.67 | Upgrade |
Other Revenue | 1.79 | 1.79 | - | - | - | - | Upgrade |
Revenue | 1.79 | 1.79 | - | - | 0.43 | 3.67 | Upgrade |
Revenue Growth (YoY) | - | - | - | - | -88.41% | -91.24% | Upgrade |
Cost of Revenue | 0.11 | 0.11 | 0.12 | 0.21 | 0.43 | 7.25 | Upgrade |
Gross Profit | 1.68 | 1.68 | -0.12 | -0.21 | -0 | -3.59 | Upgrade |
Selling, General & Admin | 18.05 | 17.93 | 15.7 | 6.75 | 79.42 | 8.74 | Upgrade |
Other Operating Expenses | - | - | - | - | 44.12 | -0.63 | Upgrade |
Operating Expenses | 18.05 | 17.93 | 15.7 | 6.64 | 145.75 | 8.11 | Upgrade |
Operating Income | -16.37 | -16.25 | -15.82 | -6.85 | -145.75 | -11.7 | Upgrade |
Interest Expense | -0.04 | -0.03 | - | - | -0.02 | - | Upgrade |
Interest & Investment Income | 1.18 | 1.64 | 0.48 | - | - | - | Upgrade |
Other Non Operating Income (Expenses) | 1.96 | 1.76 | 0.41 | -0.26 | - | - | Upgrade |
EBT Excluding Unusual Items | -13.26 | -12.88 | -14.93 | -7.11 | -145.77 | -11.7 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | - | 0.92 | - | Upgrade |
Gain (Loss) on Sale of Assets | - | - | 0.25 | 0.01 | -1.57 | 0.02 | Upgrade |
Asset Writedown | 0.14 | 0.14 | -0.97 | 0.34 | -12.67 | - | Upgrade |
Legal Settlements | 0 | 1.74 | -0.28 | - | -4.02 | - | Upgrade |
Other Unusual Items | 3.07 | 3.07 | 9.39 | 3.8 | 0.66 | - | Upgrade |
Pretax Income | -10.05 | -7.93 | -6.53 | -2.96 | -162.45 | -11.68 | Upgrade |
Income Tax Expense | 0.09 | 0.09 | - | - | - | - | Upgrade |
Net Income | -10.14 | -8.01 | -6.53 | -2.96 | -162.45 | -11.68 | Upgrade |
Net Income to Common | -10.14 | -8.01 | -6.53 | -2.96 | -162.45 | -11.68 | Upgrade |
Shares Outstanding (Basic) | 7 | 7 | 7 | 3 | 3 | 3 | Upgrade |
Shares Outstanding (Diluted) | 7 | 7 | 7 | 3 | 3 | 3 | Upgrade |
Shares Change (YoY) | -13.04% | - | 150.00% | - | - | - | Upgrade |
EPS (Basic) | -1.56 | -1.23 | -1.00 | -1.14 | -62.48 | -4.49 | Upgrade |
EPS (Diluted) | -1.56 | -1.23 | -1.00 | -1.14 | -62.48 | -4.49 | Upgrade |
Free Cash Flow | -21.1 | -19.51 | -63.57 | -0.63 | -1.84 | 1.96 | Upgrade |
Free Cash Flow Per Share | -3.25 | -3.00 | -9.78 | -0.24 | -0.71 | 0.75 | Upgrade |
Gross Margin | 93.69% | 93.69% | - | - | -0.13% | -97.77% | Upgrade |
Operating Margin | -912.35% | -906.01% | - | - | -34270.07% | -318.87% | Upgrade |
Profit Margin | -565.01% | -446.68% | - | - | -38196.54% | -318.42% | Upgrade |
Free Cash Flow Margin | -1176.24% | -1087.40% | - | - | -433.40% | 53.45% | Upgrade |
EBITDA | -15.8 | -15.75 | -15.44 | -6.43 | -144.65 | -9.91 | Upgrade |
EBITDA Margin | - | - | - | - | - | -270.23% | Upgrade |
D&A For EBITDA | 0.57 | 0.51 | 0.38 | 0.42 | 1.1 | 1.78 | Upgrade |
EBIT | -16.37 | -16.25 | -15.82 | -6.85 | -145.75 | -11.7 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.